As with non-cancer-derived cell lines, we found that loss of PBRM1 leads to a reduction in the G2/M population at late time points when compared with the nontargeting siRNA (siCON)-treated Caki-1 cells (Fig. 4B,C; Supplemental Fig. S6B). The gene discussed is PBRM1; the disease is cancer.